Redx Pharma Ltd Sustainability Reports
A clinical-stage biotechnology company focused on the discovery and development of novel small molecule targeted medicines. Its primary therapeutic focus areas include the treatment of fibrotic diseases and cancer.
Sector: Professional & technical services
Country: United Kingdom
Exchange: Unlisted
LEI: 213800HMS4EBXO589Y37
1 reports from 2024 to 2024